Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 581–600 of 18,047 drug recalls

Drug Recall Ongoing 2026 recordClass II

thiamine HCl, 500 mg, 500 mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-079-56.

by Fresenius Kabi Compounding, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
February 5, 2026
Reported by FDA
February 18, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride Injection, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-050-56

by Fresenius Kabi Compounding, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
February 5, 2026
Reported by FDA
February 18, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56

by Fresenius Kabi Compounding, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
February 5, 2026
Reported by FDA
February 18, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone 100mg Anastrozole 4mg , 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-32

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone 87.5mg, Triamcinolone Acetonide17.5 mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-6087-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone 200mg, Triamcinolone Acetonide 40mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-6200-43.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone 100mg, Triamcinolone Acetonide 20mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-6100-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone 75mg, Anastrozole 4mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4079-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone 100mg, Anastrozole 4mg (4.5), 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-01.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 303 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1303-01.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 100 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-1100-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 87.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1087-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 62.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1062-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 50.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1050-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1037-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 25.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1025-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 18.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1018-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 12.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1012-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3037-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.